Neurocrine Biosciences Inc vs Unity Software Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Unity Software Inc trades at $29.81 (market cap $13.01B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Unity Software Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | U | |
|---|---|---|
Market Cap | $17.40B | $13.01B |
Sector | Health | Technology |
52-Week High | $180.55 | $49.47 |
52-Week Low | $123.10 | $17.13 |
Enterprise Value | $16.49B | $13.11B |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →